drugset / Trial / NCT00530868
Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer
Phase 2
Completed
75 enrolled
University of Alabama at Birmingham
Breast Cancer Research Foundation · collabGenentech, Inc. · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This purpose of this trial is to show that the combination of Avastin and hormone therapy should be more effective than hormone therapy alone for the treatment of breast cancer.
Timeline
- Start
- 2007-10-08
- Primary completion
- 2022-03-01
- Completion
- 2022-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | 15 mg/kg | Intravenous |
| Subject | Letrozole | Other / unclassified | 2.5 mg | Oral |